MIG
CRSP icon

McGuire Investment Group’s CRISPR Therapeutics CRSP Stock Holding History

McGuire Investment Group’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-57,822
Closed -$2.72M – 111
2024
Q3 		$2.72M Sell
57,822
-48
-0.1% -$2.44K 0.38% 54
2024
Q2 		$3.13M Sell
57,870
-118
-0.2% -$6.83K 0.45% 51
2024
Q1 		$3.95M Sell
57,988
-609
-1% -$43.6K 0.58% 46
2023
Q4 		$3.67M Sell
58,597
-809
-1% -$44.7K 0.61% 45
2023
Q3 		$2.7M Buy
59,406
+2,368
+4% +$122K 0.52% 47
2023
Q2 		$3.2M Buy
57,038
+4,141
+8% +$235K 0.6% 44
2023
Q1 		$2.39M Buy
52,897
+17,048
+48% +$828K 0.48% 48
2022
Q4 		$1.46M Buy
35,849
+31,210
+673% +$1.66M 0.32% 54
2022
Q3 		$303K Buy
4,639
+150
+3% +$10.9K 0.07% 90
2022
Q2 		$273K Buy
4,489
+790
+21% +$46.4K 0.06% 96
2022
Q1 		$232K Buy
+3,699
New +$232K 0.04% 112
2021
Q4 		– Sell
-2,049
Closed -$229K – 124
2021
Q3 		$229K Hold
2,049
– – 0.04% 114
2021
Q2 		$332K Sell
2,049
-146
-7% -$17.8K 0.06% 92
2021
Q1 		$267K Buy
2,195
+464
+27% +$70.1K 0.06% 97
2020
Q4 		$265K Sell
1,731
-1,050
-38% -$124K 0.07% 87
2020
Q3 		$233K Sell
2,781
-470
-14% -$41.7K 0.07% 88
2020
Q2 		$239K Buy
+3,251
New +$190K 0.08% 82

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

McGuire Investment Group's CRSP Position: Q4 2024 in Review

McGuire Investment Group sold out of CRISPR Therapeutics (CRSP) in Q4 2024, closing a stake of 57,822 shares — an estimated $2.72M sold.

McGuire Investment Group first reported a position in CRSP in Q2 2020 and held it in 17 quarters. The position peaked at $3.95M in Q1 2024. 404 funds tracked by Wall St. Rank hold CRSP as of Q4 2024.

  • McGuire Investment Group reported no remaining CRISPR Therapeutics position as of Q4 2024 after selling out during the quarter.
  • McGuire Investment Group sold 57,822 CRISPR Therapeutics shares in Q4 2024, an estimated $2.72M.
  • McGuire Investment Group first reported a position in CRISPR Therapeutics in Q2 2020 and held it in 17 quarters.
  • McGuire Investment Group's CRISPR Therapeutics position peaked at $3.95M in Q1 2024.
  • 404 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q4 2024.

Based on McGuire Investment Group's 13F filing for Q4 2024, filed 21 Jan 2025.